Trial intelligence / Profile preview

Iohexol to temporarily clear corneal scars for cataract surgery

2007-001362-32Phase 2Terminated

Sponsor
University Hospitals of Leicester NHS Trust
Start
Dec 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label, single-arm trial of iohexol in corneal fibrosis and cataract, sponsored by University Hospitals of Leicester NHS Trust. Primary endpoints: Maximum change in corneal clarity after iohexol application and Change in visual acuity following cataract extraction. Started Dec 2007; status: terminated.

02

Drugs

iohexol
03

Conditions

corneal fibrosiscataract

Beyond the preview

Go deeper on 2007-001362-32.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-001362-32.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call